Literature DB >> 7131970

Translateral retroperitoneal approach in radical surgery for pancreatic carcinoma.

T Nagakawa, M Kurachi, K Konishi, I Miyazaki.   

Abstract

Investigations of the lymphatic routes using dye during operations and histological studies on the resected specimen of the pancreas and autopsied cases with pancreatic carcinoma have led to the conclusion that the surgery should be performed more extensively to improve the results and should consist of a complete lymphatic excision surrounding the celiac axis and the trunk of the superior mesenteric artery including dissection of the nerve plexus and wide retroperitoneal dissection surrounding the pancreas, upwards to the level of adrenal glands, and downwards to the level of iliac bifurcation. A translateral retroperitoneal approach was found to be the most useful and safe method for such extended resection in patients with pancreatic carcinoma. Our radical procedure for pancreatic carcinoma is described herein.

Entities:  

Mesh:

Year:  1982        PMID: 7131970     DOI: 10.1007/bf02469594

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  3 in total

1.  RADICAL PANCREATODUODENECTOMY: A 22-YEAR EXPERIENCE WITH THE COMPLICATIONS, MORTALITY RATE, AND SURVIVAL RATE.

Authors:  J J MONGE; E S JUDD; R P GAGE
Journal:  Ann Surg       Date:  1964-10       Impact factor: 12.969

2.  Results of radical resection for periampullary cancer.

Authors:  K W Warren; D S Choe; J Plaza; M Relihan
Journal:  Ann Surg       Date:  1975-05       Impact factor: 12.969

3.  Regional pancreatectomy: en bloc pancreatic, portal vein and lymph node resection.

Authors:  J G Fortner; D K Kim; A Cubilla; A Turnbull; L D Pahnke; M E Shils
Journal:  Ann Surg       Date:  1977-07       Impact factor: 12.969

  3 in total
  21 in total

1.  Does extended pancreaticoduodenectomy increase operative morbidity and mortality vs. standard pancreaticoduodenectomy?

Authors:  C Iacono; L Bortolasi; E Facci; G Falezza; G Prati; G Mangiante; G Serio
Journal:  J Gastrointest Surg       Date:  1997 Sep-Oct       Impact factor: 3.452

2.  Patterns of neural and plexus invasion of human pancreatic cancer and experimental cancer.

Authors:  T Nagakawa; M Kayahara; T Ohta; K Ueno; I Konishi; I Miyazaki
Journal:  Int J Pancreatol       Date:  1991-10

Review 3.  Meta-analysis of the efficacies of extended and standard pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas.

Authors:  Jingfeng Sun; Yinxue Yang; Xuan Wang; Zhen Yu; Ting Zhang; Jun Song; Hewei Zhao; Jianfei Wen; Yong Du; Wan Yee Lau; Yewei Zhang
Journal:  World J Surg       Date:  2014-10       Impact factor: 3.352

4.  A phase I study of preoperative (neoadjuvant) chemotherapy with gemcitabine plus nab-paclitaxel for resectable pancreatic cancer.

Authors:  Hidehiro Tajima; Isamu Makino; Ryosuke Gabata; Mitsuyoshi Okazaki; Yoshinao Ohbatake; Hiroyuki Shimbashi; Shinich Nakanuma; Hiroto Saitoh; Mari Shimada; Takahisa Yamaguchi; Koichi Okamoto; Hideki Moriyama; Jun Kinoshita; Keishi Nakamura; Tomoharu Miyashita; Itasu Ninomiya; Sachio Fushida; Hiroko Ikeda; Tetsuo Ohta
Journal:  Mol Clin Oncol       Date:  2020-12-14

5.  Pancreatic resection for periampullary carcinoma in the elderly.

Authors:  M Kayahara; T Nagakawa; K Ueno; T Ohta; T Takeda; I Miyazaki
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

6.  Neoadjuvant chemotherapy for pancreatic cancer: Effects on cancer tissue and novel perspectives.

Authors:  Hidehiro Tajima; Isamu Makino; Yoshinao Ohbatake; Shinichi Nakanuma; Hironori Hayashi; Hisatoshi Nakagawara; Tomoharu Miyashita; Hiroyuki Takamura; Tetsuo Ohta
Journal:  Oncol Lett       Date:  2017-04-07       Impact factor: 2.967

7.  Aggressive resection for advanced pancreatic carcinoma.

Authors:  S Sunada; M Miyata; Y Tanaka; K Okumura; M Nakamuro; T Kitagawa; R Shirakura; Y Kawashima
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

8.  Giant serous microcystic adenoma of the pancreas safely resected after preoperative arterial embolization.

Authors:  Hidehiro Tajima; Tetsuo Ohta; Hirohisa Kitagawa; Hiroyuki Shinbashi; Atsushi Hirose; Seisho Sakai; Isamu Makino; Hironori Hayashi; Hisatoshi Nakagawara; Ichiro Onishi; Hiroyuki Takamura; Itasu Ninomiya; Sachio Fushida; Takashi Tani; Takashi Fujimura; Masato Kayahara; Wataru Koda; Osamu Matsui
Journal:  Oncol Lett       Date:  2010-09-01       Impact factor: 2.967

9.  Pilot study of neoadjuvant chemotherapy with gemcitabine and oral S-1 for resectable pancreatic cancer.

Authors:  Hidehiro Tajima; Tetsuo Ohta; Hirohisa Kitagawa; Koichi Okamoto; Seisho Sakai; Isamu Makino; Jun Kinoshita; Hiroyuki Furukawa; Keishi Nakamura; Hironori Hayashi; Katsunobu Oyama; Masafumi Inokuchi; Hisatoshi Nakagawara; Hideto Fujita; Hiroyuki Takamura; Itasu Ninomiya; Sachio Fushida; Takashi Tani; Takashi Fujimura; Hiroko Ikeda; Seiko Kitamura
Journal:  Exp Ther Med       Date:  2012-02-13       Impact factor: 2.447

10.  The pattern of lymph node involvement in carcinoma of the head of the pancreas. A histologic study of the surgical findings in patients undergoing extensive nodal dissections.

Authors:  T Nagakawa; H Kobayashi; K Ueno; T Ohta; M Kayahara; K Mori; T Nakano; T Takeda; I Konishi; I Miyazaki
Journal:  Int J Pancreatol       Date:  1993-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.